Communiqués Futura Medical plc OTC Markets

Actions

FAMDF

GB0033278473

Recherche biotechnologique et médicale

Temps Différé OTC Markets 18:20:30 22/09/2026			Varia. 5j.	Varia. 1 janv.
0,002000 ^USD	-23,08%		+4,00%	-85,45%

16/09	PALMARÈS : Filtronic décroche un contrat ; les résultats de Cirata en baisse	AN
14/09	GAGNANTS & PERDANTS : Tribal va céder ses actifs ; Brave Bison relève son offre sur System1	AN

Communiqués

13/11	Futura Medical : CIRCULAR- PLACING AND SUBSCRIPTION OF 275,000,000 NEW SHARES AT 1 PENCE PER SHARE AND NOTICE OF GENERAL MEETING	PU
13/11	Futura Medical : Letter to Shareholder Circular and Notice of the General Meeting	PU
27/05/25	Futura Medical : Notice of AGM 2025	PU
10/09/24	Futura Medical : Interim Results 2024	PU
24/05/24	Futura Medical : Annual Report 2023	PU
24/05/24	Futura Medical : Letter to shareholder - Notice of AGM and Annual Report	PU
24/05/24	Futura Medical : Notice of AGM 2024	PU
11/04/24	Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024	AQ
08/02/24	Futura Medical marks pivotal year with first meaningful revenue from Eroxon sales	AQ
07/11/23	Futura Medical continues global expansion with Latin America announcement	AQ
18/09/23	Futura Medical "on track for a profit in 2025" after strong first half	AQ
19/07/23	Futura Medical "absolutely delighted" with US commercialisation agreement	AQ
12/06/23	US FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile Dysfunction	BU
23/05/23	Futura Medical : Annual Report 2022	PU
22/05/23	Futura Medical : Notice of AGM 2023	PU
18/04/23	Futura Medical debuts Eroxon in UK and says "more launches coming"	AQ
06/04/23	Futura Medical "confident of getting FDA approval this quarter"	AQ
14/03/23	Futura Medical expects FDA approval for topical ED treatment during Q2	AQ
13/12/22	Futura Medical "on track" for launch in H1 2023	AQ
13/12/22	Futura Medical 'on track' for launch in H1 2023	EQ
31/08/22	Highly positive FM71 Phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to submit for FDA marketing authorization	BU
29/09/21	Futura Medical : Interim results September 2021	PU
25/06/21	Futura Medical : AGM 2021 Questions Statement	PU
28/05/21	Futura Medical : General Meeting Shareholders Questions Statement	PU
14/04/21	Futura Medical : Investor Presentation year ended 31 December 2020	PU